Back to top
more

Arcellx (ACLX)

(Delayed Data from NSDQ)

$65.92 USD

65.92
701,526

+2.57 (4.06%)

Updated Jul 16, 2024 04:00 PM ET

After-Market: $65.89 -0.03 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ACLX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Arcellx, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 704 255 105 47 -99,999
Receivables 0 0 0 0 NA
Notes Receivable 0 0 0 0 NA
Inventories 0 0 0 0 NA
Other Current Assets 12 12 8 3 NA
Total Current Assets 716 267 113 49 NA
Net Property & Equipment 43 11 10 5 NA
Investments & Advances 27 0 0 0 NA
Other Non-Current Assets 0 0 0 0 NA
Deferred Charges 0 0 3 2 NA
Intangibles 0 0 0 0 NA
Deposits & Other Assets 12 7 2 2 NA
Total Assets 825 314 129 58 NA
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 NA
Accounts Payable 3 9 1 1 NA
Current Portion Long-Term Debt 0 0 0 0 NA
Current Portion Capital Leases 39 33 0 0 NA
Accrued Expenses 18 12 13 5 NA
Income Taxes Payable 0 0 0 0 NA
Other Current Liabilities 51 0 0 0 NA
Total Current Liabilities 118 57 15 5 NA
Mortgages 0 0 0 0 NA
Deferred Taxes/Income 0 0 0 0 NA
Convertible Debt 0 0 0 0 NA
Long-Term Debt 0 0 0 0 NA
Non-Current Capital Leases 0 21 0 0 NA
Other Non-Current Liabilities 171 0 2 2 NA
Minority Interest (Liabilities) 0 0 0 0 NA
Total Liabilities 340 109 17 7 NA
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 233 114 NA
Common Stock (Par) 0 0 0 0 NA
Capital Surplus 874 524 9 1 NA
Retained Earnings -389 -319 -130 -65 NA
Other Equity 1 0 0 0 NA
Treasury Stock 0 0 0 0 NA
Total Shareholder's Equity 485 205 112 51 NA
Total Liabilities & Shareholder's Equity 825 314 129 58 NA
Total Common Equity 485 205 -122 -64 0
Shares Outstanding 48.60 43.80 25.20 NA NA
Book Value Per Share 9.99 4.68 -4.82 0.00 0.00

Fiscal Year End for Arcellx, Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 574 704 440 506
Receivables NA 0 0 31 29
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 15 12 20 22
Total Current Assets NA 589 716 491 558
Net Property & Equipment NA 45 43 38 22
Investments & Advances NA 117 27 43 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 5 12 13 14
Total Assets NA 780 825 614 624
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 3 3 7 6
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 33 39 48 38
Accrued Expenses NA 34 18 17 12
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 31 51 94 94
Total Current Liabilities NA 108 118 173 156
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 6 9
Other Non-Current Liabilities NA 171 121 124
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 283 340 348 330
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 894 874 675 664
Retained Earnings NA -397 -389 -409 -370
Other Equity NA -1 1 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 497 485 266 294
Total Liabilities & Shareholder's Equity NA 780 825 614 624
Total Common Equity 0 497 485 266 294
Shares Outstanding 53.50 53.20 48.60 48.30 48.00
Book Value Per Share 0.00 9.33 9.99 5.51 6.12